Clincosm LogoSign in Get a demo

Plaqenil Role in Prevention of Age Related Macular Degeneration

Sponsor
Ziv Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01541449
Collaborator
(none)
30
Enrollment
1
Location
3
Duration (Months)
10
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The investigators think that there is a connection between the use of plaquenil and the prevention of Age related macular degeneration (AMD). The investigators believe that the use of plaquenil makes bruch's membrane thicker, thereby preventing Chroidal Neovascularization (CNV) growth.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    the study is done by comparing to groups RA patients who take plaquenil Vs. group of patients who do not take plaquenil. after measuring the retina thickness we compare the avg. thickness of both groups.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    30 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Observational Study Between People That Use Plaquenil and Those Who do Not in Prevention of AMD.
    Study Start Date :
    Jan 1, 2012
    Anticipated Study Completion Date :
    Apr 1, 2012

    Arms and Interventions

    Arm Intervention/Treatment
    RA patients treated with plaquenil
    Patients who do not use plaquenil

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      20 Years to 80 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:
      • all people who suffer from rheumatoid arthritis (RA) and use plaquenil
      Exclusion Criteria:
      • patients who did not complete follow-up

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Ziv Medical Center Safed Israel 13100

      Sponsors and Collaborators

      • Ziv Hospital

      Investigators

      • Principal Investigator: Joseph pikkel, M.D, Ziv Medical Center

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      Ziv Hospital
      ClinicalTrials.gov Identifier:
      NCT01541449
      Other Study ID Numbers:
      • ZIV-0061-11
      First Posted:
      Mar 1, 2012
      Last Update Posted:
      Mar 1, 2012
      Last Verified:
      Jan 1, 2012
      Keywords provided by Ziv Hospital
      AMD
      PLAQUENIL
      CNV
      Additional relevant MeSH terms:
      Macular Degeneration

      Study Results

      No Results Posted as of Mar 1, 2012